NEW MEDICARE APPROVED CLINICAL TRIAL FOR ALZHEIMER'S DIAGNOSTIC TOOL!

CMS-Medicare recently approved reimbursement for Medicare eligible beneficiaries who enroll in a clinical trial to evaluate the diagnostic benefit of new amyloid-based imaging agents approved for the diagnosing and evaluation of suspected Alzheimer's disease.  This trial is open to all Medicare eligible beneficiaries who enroll in this trial through an IDEAS-study approved physician.  Trident PET/CT of Savannah is pleased to announce that we are the first, and currently the only, PET facility in Georgia approved to participate in this clinical trial.  Please click on the link below to locate a physician near you that has been approved to refer patients to Trident PET for this new diagnostic scan for Alzheimer's disease.

 

alt